Showing results (711-720 of 857) with videos related to

Sort By:
Pageof 86
NMR in Biomedicine|April 2, 2025
Hyperpolarized 13C-MRS can Quantify Lactate Production and Oxidative PDH Flux in Murine Skeletal Muscle During ExerciseM Kate Curtis, Jordan J McGing, Brianna J Stubbs, et al.
Regulatory Toxicology and Pharmacology : RTP|June 9, 2009
Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug productG Eichenbaum, M Johnson, D Kirkland, et al.
Neuro-Oncology Practice|December 8, 2015
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance)Paul D Brown, S Keith Anderson, Xiomara W Carrero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivorsEric C Burton, Kathleen R Lamborn, Peter Forsyth, et al.
The Journal of Invasive Cardiology|February 3, 2025
Safety and complications associated with the use of protamine in percutaneous coronary interventionHussayn Alrayes, Ayman Alsaadi, Ahmad Alkhatib, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|February 5, 2026
Trends in incidence, management and survival in medullary thyroid cancer in Ireland - A 25-year population-based studyT J Crotty, G P Sexton, E F Cleere, et al.
Molecular Pharmacology|October 15, 2010
Pharmacological characterization of MK-7246, a potent and selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T-helper type 2 cells) antagonistFrancois G Gervais, Nicole Sawyer, Rino Stocco, et al.
Biochemical Pharmacology|October 11, 1996
Mechanism of selective inhibition of human prostaglandin G/H synthase-1 and -2 in intact cellsS Kargman, E Wong, G M Greig, et al.
Circulation|September 17, 2003
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodelingWilliam M Yarbrough, Rupak Mukherjee, G Patricia Escobar, et al.
Oncogene|August 10, 2004
Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cellsFarhat L Khanim, Lyndon M Gommersall, Victoria H J Wood, et al.
Pageof 86